Role for calcium-activated potassium channels (BK) in growth control of human malignant glioma cells

被引:103
|
作者
Weaver, AK [1 ]
Liu, XJ [1 ]
Sontheimer, H [1 ]
机构
[1] Univ Alabama Birmingham, Dept Neurobiol, Civitan Int Res Ctr, Birmingham, AL USA
关键词
BK channel; glioma; proliferation; iberiotoxin; cell growth;
D O I
10.1002/jnr.20240
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Voltage-dependent large-conductance Ca2+-activated K+ channels, often referred to as BK channels, are a unique class of ion channels coupling intracellular chemical signaling to electrical signaling. BK channel expression has been shown to be up-regulated in human glioma biopsies, and expression levels correlate positively with the malignancy grade of the tumor. Glioma BK channels (gBK) are a splice variant of the hslo gene, are characterized by enhanced sensitivity to [Ca2+](i), and are the target of modulation by growth factors. By using the selective pharmacological BK channel inhibitor iberiotoxin, we examined the potential role of these channels in tumor growth. Cell survival assays examined the ability of glioma cells to grow in nominally serum-free medium. Under such conditions, BK channel inhibition by iberiotoxin caused a dose- and time-dependent decrease in cell number discernible as early as 72 hr after exposure and maximal growth inhibition after 4-5 days. FACS analysis shows that IbTX treatment arrests glioma cells in S phase of the cell cycle, whereupon cells undergo cell death. Interestingly, IbTX effects were nullified when cells were maintained in 7% fetal calf serum. Electrophysiological analysis, in conjunction with biotinylation studies, demonstrates that serum starvation caused a significant translocation of BK channel protein to the plasma membrane, corresponding to a two- to threefold increase in whole-cell conductance, but without a change in total gBK protein. Hence, expression of functional gBK channels appears to be regulated in a growth-factor-dependent manner, with enhanced surface expression promoting tumor cell growth under conditions of growth factor deprivation as might occur under in vivo conditions. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:224 / 234
页数:11
相关论文
共 50 条
  • [1] Role of calcium-activated potassium (BK) channels in glioma cell migration
    Kraft, R
    Krause, P
    Patt, S
    GLIA, 2002, : S55 - S55
  • [2] Role for calcium-activated potassium channels (BK) in migration control of human hepatocellular carcinoma cells
    He, Yuan
    Lin, Yingying
    He, Fei
    Shao, Lijuan
    Ma, Wei
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2021, 25 (20) : 9685 - 9696
  • [3] Expression and function of calcium-activated potassium channels in human glioma cells
    Weaver, Amy K.
    Bomben, Valerie C.
    Sontheimer, Harald
    GLIA, 2006, 54 (03) : 223 - 233
  • [4] The role of calcium-activated potassium channels in respiratory control
    Bissonnette, JM
    RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY, 2002, 131 (1-2) : 145 - 153
  • [5] Oxidative Stress and Maxi Calcium-Activated Potassium (BK) Channels
    Hermann, Anton
    Sitdikova, Guzel F.
    Weiger, Thomas M.
    BIOMOLECULES, 2015, 5 (03): : 1870 - 1911
  • [6] CALCIUM-ACTIVATED POTASSIUM CHANNELS AND THEIR ROLE IN SECRETION
    PETERSEN, OH
    JOURNAL OF CELL BIOLOGY, 1983, 97 (05): : A124 - A124
  • [7] CALCIUM-ACTIVATED POTASSIUM CHANNELS AND THEIR ROLE IN SECRETION
    PETERSEN, OH
    MARUYAMA, Y
    NATURE, 1984, 307 (5953) : 693 - 696
  • [8] CALCIUM-ACTIVATED POTASSIUM CHANNELS IN HUMAN PLATELETS
    FINE, BP
    HANSEN, KA
    SALCEDO, JR
    AVIV, A
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1989, 192 (02): : 109 - 113
  • [9] CALCIUM-ACTIVATED POTASSIUM CHANNELS IN HUMAN PLATELETS
    MAHAUTSMITH, MP
    JOURNAL OF PHYSIOLOGY-LONDON, 1995, 484 (01): : 15 - 24
  • [10] Big conductance calcium-activated potassium (BK) channels in breast cancer
    Mohr, C. J.
    Steudel, F. A.
    Lo, W. -Y.
    Schroth, W.
    Hoppe, R.
    Stegen, B.
    Huber, S. M.
    Ruth, P.
    Brauch, H.
    Lukowski, R.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 188 - 188